RUWAG

Bettlach, Switzerland Founded: 1987 • Age: 39 yrs Acquired By Calibre Scientific
Distributor of drugs

About RUWAG

RUWAG is a Healthcare company based in Bettlach (Switzerland) founded in 1987, and was acquired by Calibre Scientific in January 2024. Distributor of drugs. RUWAG offers products and services including Diagnostics Products, Life Science Products, and Allergy Products. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is RUWAG Handels AG. Its competitors include Xantis Pharma, DCS Pharma and Globomedica.

Company details

RUWAG was established in 1987 in Bettlach, Switzerland, as a distributor in the life sciences sector. Diagnostic instruments, transfection devices, and biobanking solutions are provided to support research and medical applications. Additionally, accessories for power tools are supplied to the artisan and DIY markets. Operations focus on efficient distribution across these specialized areas within Switzerland.

  • Headquarters Bettlach, Switzerland
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ruwag.ch
  • Social LinkedIn
  • Acquired by Calibre Scientific (Jan 2024)
  • Legal Name Ruwag Handels Ag
Key Metrics

Products & Services of RUWAG

RUWAG offers a comprehensive portfolio of products and services, including Diagnostics Products, Life Science Products, and Allergy Products.

Diagnostics Products
Medical Diagnostics

Products for testing and diagnostics in healthcare settings

Life Science Products
Biotechnology

Tools for research and development in life sciences

Allergy Products
Medical Supplies

Items for allergy testing and related applications

Investors in RUWAG

RUWAG has secured backing from 1 investor. Prominent investors backing the company include Calibre Scientific.

All
InvestorDescriptionFounded YearDomainLocation
Provider of contract based research, manufacturing, distribution and other services for biopharma sector
2016calibrescientific.comLos Angeles, United States
Premium access

Investor details for RUWAG

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of RUWAG

1 people are tracked at RUWAG (1 in leadership).

NameRoleGroup
Daniel Rothenbuehler
OwnerLeadership
Premium access

Complete people profiles for RUWAG

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of RUWAG

2 dated milestones of RUWAG across 37 years, from founding to its latest funding, stage changes and deals.

  1. Founded RUWAG is founded.
  2. Exit Acquired by Calibre Scientific.

Competitors of RUWAG

RUWAG has 3 listed competitors in our database. They include Xantis Pharma, DCS Pharma and Globomedica.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
xantispharma.com2015Zug, Switzerland
Distributor of generic prescription and over-the-counter products
dcspharma.com2016Basel, Switzerland
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
globomedica.ch2009Egg, Switzerland
Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland.
Premium access

Detailed competitors of RUWAG

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of RUWAG

The website of RUWAG (ruwag.ch) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▼ 11.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ruwag

Calibre Scientific AG’s Acquisition of Ruwag Handels AG
Globallegalchronicle β€’ 2 years ago
Premium access

Complete news archive for RUWAG

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RUWAG

RUWAG was founded in 1987.

RUWAG is headquartered in Bettlach, Switzerland. It is registered at Bettlach, Solothurn, Switzerland.

RUWAG was established in 1987 in Bettlach, Switzerland, as a distributor in the life sciences sector. Diagnostic instruments, transfection devices, and biobanking solutions are provided to support research and medical applications. Additionally, accessories for power tools are supplied to the artisan and DIY markets. Operations focus on efficient distribution across these specialized areas within Switzerland.

RUWAG's top competitors include DCS Pharma, Globomedica and Xantis Pharma.

RUWAG offers Diagnostics Products, Life Science Products, and Allergy Products.

RUWAG has 1 investor. Key investors include Calibre Scientific.

RUWAG operates through Ruwag Handels Ag.

Yes. RUWAG was acquired by Calibre Scientific in January 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available